Form 4 for ATEX Anterix Inc.
Accepted 2021-11-09 00:00:00 ET · period of report 2021-11-05 · accession 0001209191-21-063708 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-09 | 2021-11-05 | ATEX | Ashe Gena L | CLO, Corp Sec | S - Sale | $61.96 | -997 | 34.1K | -3% | -$61.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-05 | S | D | 997 | $61.96 | 34,123 | D | — | — | (F1) This transaction was executed in multiple sales through a sale order executed by a broker-dealer at prices ranging from $61.9631 to $61.9634. The price reported in this column reflects the weighted average sale price. The Reporting Person will provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. |